SYS Pharma Corp
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from SYS Pharma Corp between 17 Dec 2025 and 13 Jul 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
SYS Pharma Corp
Retatrutide
Tested 4 Samples
Last test 13 Jul 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from SYS Pharma Corp
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
13 Jul 2026
First
17 Dec 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 13 Jul 2026 | View | 20mg | 19.6mg | -2.0% | 99.90% | below LOQ | 20251103V | No label / Silver crimp / Black cap | Lab E | Public | |
| 28 Apr 2026 | View | 30mg | 29.1mg | -3.0% | 99.90% | n/a | 20251218V | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 12 Mar 2026 | View | 10mg | 8.24mg | -17.6% | 99.90% | n/a | (no batch ID) | White Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 17 Dec 2025 | View | 20mg | 12mg | -40.0% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |